BBlogFlow

Statins can safely cut risk of heart attacks or strokes in healthy people aged over 70, world-first clinical trial shows - The Guardian

·Aug 29, 2026
Source: The Guardian
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. The Guardian

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

A staggering number of Americans now have high cholesterol, say doctors. But statins might not be the answer - BBC Science Focus Magazine

When is your cholesterol high enough that you need medication? You might expect there to be a simple cut-off. Above this number, you need statins. Below it, you don’t. But doctors don’t just look at your cholesterol in isolation. It’s fed into a formula – alongside variables like your age, blood pressure, medical history and lifestyle – that estimates your overall risk of having a heart attack or stroke in the years ahead. Rewrite the formula slightly and suddenly you could find yourself being offered statins.

BBC Science Focus Magazine·

Bioengineer.org | Viral blips during HIV therapy are common and rarely signal treatment failure, Swedish study finds - European AIDS Treatment Group

Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.

European AIDS Treatment Group·

European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group

European Medical Journal news storyPeople living with HIV may experience subtle changes in heart muscle function even when conventional measures of cardiac performance remain normal, according to findings from a systematic review and meta-analysis. Researchers identified significantly impaired global longitudinal strain (GLS) among people with HIV compared with HIV-uninfected individuals, despite preserved left ventricular ejection fraction (LVEF) in both groups. The findings suggest that speckle-tracking echocardiography (STE) could provide additional information about early myocardial dysfunction in this population. Read the full news story here.

European AIDS Treatment Group·